Johnson & Johnson COVID Vaccine Produces Strong Immune Response In Trial
A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim...
Comments
Post a Comment